About this product
Overview
Linzim DS Syrup, fortified with the potent antibiotic Cefixime, emerges as a stalwart defender against bacterial infections. Cefixime, a third-generation cephalosporin, is renowned for its efficacy in treating a diverse range of bacterial ailments, providing a reliable solution for patients in need of targeted antibacterial therapy.
Uses
Linzim DS Syrup is a versatile medication used to combat various bacterial infections. Its spectrum of activity extends to respiratory tract infections, urinary tract infections, otitis media, and other susceptible bacterial conditions. Cefixime, the active ingredient, exerts its bactericidal effect by inhibiting bacterial cell wall synthesis.
Dosage and Administration
The syrup is typically administered orally, with the dosage tailored to the specific infection and the patient’s age and weight. It is crucial to complete the prescribed course, even if symptoms improve, to ensure the eradication of the infection and prevent the development of antibiotic resistance.
Side Effects
While Linzim DS Syrup is generally well-tolerated, some individuals may experience mild side effects such as gastrointestinal disturbances (nausea, diarrhea), headache, or skin rash. Serious allergic reactions are rare but require immediate medical attention.
Precautions
- Allergic Reactions: Individuals with known hypersensitivity to cephalosporins or penicillins should exercise caution and consult a healthcare professional.
- Renal Impairment: Dose adjustments may be necessary for patients with impaired renal function.
When Not to Use
Linzim DS Syrup is contraindicated in patients with a history of severe allergic reactions to cephalosporins. Additionally, caution is warranted in individuals with a history of gastrointestinal diseases, as antibiotics can sometimes disrupt the balance of intestinal flora.
Other brands of Cefixime
These medicines also contain Cefixime, but in a different strength or pack. Do not switch to a different strength without asking your doctor.
| Medicine | Manufacturer | Strength | Price |
|---|---|---|---|
| Cezox 100mg Syrup | Asian Continental | 100mg | Rs 230.17 |
| M-Span Syrup 100mg/5ml | Aspin Pharma | 100mg/5ml | Rs 240.85 |
| Triban 100mg/5ml Syrup | - | 100mg/5ml | Rs 270 |
| M-Span Ds Syrup | Aspin Pharma | - | Rs 294.74 |
| Cinklare 100 mg Syrup | AGP Pharmacuticals | 100mg | Rs 295.37 |
| Cezox Ds Syrup | Asian Continental | - | Rs 306.24 |
| Cinklare 200 mg Syrup | AGP Pharmacuticals | 200mg | Rs 371.94 |
| Ceflit 100mg|5ml syrup | Mcolson Research Labotraies | 100mg | Rs 372 |
See all brands and prices on our Cefixime page.
Frequently asked questions
Can Linzim DS Syrup be taken with food?
It can be taken with or without food, but consistency in administration is recommended.
How quickly does it show improvement in symptoms?
Individual responses vary, but symptomatic relief is often noticeable within a few days of starting treatment.
Is it safe for use during pregnancy?
Consult a healthcare professional before using Linzim DS Syrup during pregnancy or breastfeeding.
Are there any specific storage conditions?
Store the syrup at room temperature, away from direct sunlight and moisture.
Can it be used for viral infections?
No, Linzim DS Syrup is effective only against bacterial infections and is not suitable for viral illnesses.
In conclusion, Linzim DS Syrup, armed with Cefixime, stands as a reliable ally in the fight against bacterial infections. Adherence to prescribed guidelines, awareness of potential side effects, and open communication with healthcare professionals contribute to the optimal use of this antibiotic, ensuring a targeted and effective response to bacterial challenges. Always seek medical advice for personalized information tailored to individual health circumstances.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
Customer reviews
You must be logged in to post a review.
Reviews
Clear filtersThere are no reviews yet.